SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS) -- Ignore unavailable to you. Want to Upgrade?


To: Spider Valdez who wrote (3669)6/25/1999 10:14:00 AM
From: G.P.  Read Replies (1) | Respond to of 4028
 
Yale Researcher Joins CYGS Scientific Advisory Board

HOUSTON--(BUSINESS WIRE)--June 25, 1999--Cryogenic Solutions Inc. (OTC BB:CYGS - news) announced the addition to the company's Scientific Advisory Board of Peter M. Glazer, MD, PhD.

Dr. Glazer holds academic degrees from Harvard (BA), Oxford (MS), and Yale (PhD) and a Medical Degree from Yale University School of Medicine where he is an Associate Professor of Therapeutic Radiology and Genetics.

His research interests include gene targeting and gene therapy, genetic instability in cancer, mutagenesis, and DNA repair.

''We are pleased to be joined by an innovative scientist like Dr. Glazer who is creative in applying interdisciplinary applications of molecular biology,'' commented Malcolm Skolnick, PhD, JD, chairman of the CYGS Scientific Advisory Board. Dr. Glazer came to the attention of CYGS when he requested one of the company's ssDNA Intracellular Expression Vector Beta Test Kits.

----------------------------------------------------------------------
Contact:

Cryogenic Solutions Inc., Houston
Dell Gibson, 713/780-1399